All In MedTech

Device Trial Radar · NCT04338516

Ridge Preservation Using a Ossix™ Bone vs Bio-Oss® Collagen

Histological Evaluation of Healing Following Ridge Preservation Using a Composite Bovine Derived Xenograft or a Hydroxyapatite-Collagen Matrix

Last checked: Nov 19, 2026Latest source record: Dec 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

54

Actual

Start

Nov 1, 2019

Primary completion

Dec 30, 2021

Study completion Mar 10, 2022

Sponsor

Lead sponsor
Datum Dental LTDNot on our public-company list
Sponsor type
Industry
First posted
Apr 8, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized, parallel design, controlled study will assess the histologic healing of this Ossix™ Bone in humans and compare it to a Bio-Oss® Collagen that is well researched. Subjects will be enrolled into 2 groups. Each subject will provide a single non-molar tooth site for study treatment. The tooth will be extracted, the extraction socket will be filled with one of the study bone grafts. No wound dressing or membrane will be used to cover the bone graft material as both materials can be used alone. An core biopsy will be collected after 16 weeks of healing during the implant placement. The study will evaluate if there is a difference in histologic wound healing following tooth extraction and ridge preservation between groups treated with Bio-Oss® Collagen compared to Ossix™ Bone.

Conditions

  • TEETH EXTRACTION

Interventions

  • Ossix™ BoneDevice

    a resorbable sponge-like matrix of 80% hydroxyapatite and 20% sugar cross-linked porcine collagen

  • Bio-Oss® CollagenDevice

    90% bovine derived xenograft granules and 10% porcine collagen

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Vital Bone Formation,Time frame: 16 weeks
  2. Percent Residual Graft MaterialTime frame: 16 weeks
  3. Percent Fibrous Tissue and Marrow SpaceTime frame: 16 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • UT Health San Antonio (UTHSA)

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.